Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3640-3646

  Shimura, Hiroki ^a   Suzuki, Hideyo ^a   Miyazaki, Asako ^a   Furuya, Fumihiko ^a   Ohta, Kazuyasu ^a   Haraguchi, Kazutaka ^a   Endo, Toyoshi ^a   Onaya, Toshimasa ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADTGTK; ADTTF 1; CYTOTOXIC AGENT; GANCICLOVIR; RECOMBINANT PROTEIN; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROID TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SUICIDE GENE; THYROID CANCER; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALS; CARCINOMA, PAPILLARY; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; SIMPLEXVIRUS; THYMIDINE KINASE; THYROGLOBULIN; THYROID NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035328634     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Thyroid tumors
2. Natural history, treatment, and course of papillary thyroid carcinoma
3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
4. Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases
5. Anaplastic carcinoma of the thyroid: A clinicopathogic study of 121 cases
6. The thyroid gland
7. The use of DNA viruses as vectors for gene therapy
8. Human gene therapy
9. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a Phase I clinical trial in malignant mesothelloma
10. In situ gene therapy for adenocarcinoma of the prostate: A Phase I clinical trial
11. A Phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiform by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
12. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
13. Directed enzyme pro-drag gene therapy for pancreatic cancer in vivo
14. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro
15. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach
16. TSH-receptor expression and human thyroid disease: Relation of clinical, endocrine, and molecular thyroid parameters
17. Iodide symporter gene expression in human thyroid tumors
18. Thyroid-specific gene expression in the multiple-step process of thyroid carcinogenesis
19. Characterization of the 5′-flanking region of the rat thyrotropin receptor gene
20. Thyroid-specific expression and cyclic adenosine 3′, 5′-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1
21. +/I- symporter gene
22. +/I- symporter gene expression
23. The paired-domain transcription factor Pax-8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription
24. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells
25. Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes
26. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa
27. Expression of thyroid-related genes in human thymus
28. Renal expression of two "thyroid-specific" genes: Thyrotropin receptor and thyroglobulin
29. Specific ablation of thyroid follicle cells in adult transgenic mice
30. Adenoviral infection of thyroid cells: A rationale for gene therapy for metastatic thyroid carcinoma
31. Thyroid-specific gene expression
32. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity
33. Thyroid-specific enhancer-binding protein (T/EBP): Cdna cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1
34. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland
35. Pax-8, a paired domain-containg protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters
36. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation
37. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain
38. The mRNA levels of thyrotropin receptor, thyroglobulin, and thyroid peroxidase in neoplastic human thyroid tissues
39. Distant metastases in differentiated thyroid carcinomas: A clinical and pathologic study
40. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms
41. Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the β-adrenergic receptor
42. Extraction, purification, and analysis of messenger RNA from eukaryotic cells
43. Regulation of thyrotropin receptor gene expression in 3T3-L1 adipose cells is distinct from its regulation in FRTL-5 thyroid cells
44. Tumor necrosis factor-α and interferon-γ suppress both gene expression and deoxyribonucleic acid-binding of TTF-2 in FRTL-5 cells
45. Plasmid DNA preparation. Tritonlysozyme method
46. A new technique for the assay of infectivity of human adenovirus 5 DNA
47. Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1
48. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines
49. Transfection of TTF-1 gene induces thyroglobulin gene expression in undifferentiated FRT cells
50. v-Ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A
51. The DNA binding activity and the dimerization ability of the thyroid transcription factor I are redox regulated
52. Redox regulation of thyroid-transcription factors, Pax-8, and TTF-1 is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells
53. Expression and function of the homeodomain-containing protein Hex in thyroid cells
54. Peripheral airway cell differentiation in human lung cancer cell lines
55. Properties and regulation of ion channels in MDCK cells
56. Intracellular metabolism and enzymatic phosphorylation of 9-(1, 3-dihydroxy-2-propoxymethyl) guanine and acyclovir in herpes simplex virus-infected and uninfected cells
57. Antiviral activity and mechanism of action of ganciclovir
58. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
59. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins